1.
Formulation Designing Factors for Development of Repaglinide Transdermal Therapeutic System. Int. J. Pharm. Sci. Drug Res. [Internet]. 2020 Mar. 30 [cited 2025 Oct. 16];12(2):148-5. Available from: https://ijpsdronline.com/index.php/journal/article/view/1335